Treatment Individualization in Colorectal Cancer
Colorectal cancer has been characterized as a genetically heterogeneous disease, with a large diversity in molecular pathogenesis resulting in differential responses to therapy. However, the currently available validated biomarkers KRAS, BRAF, and microsatellite instability do not sufficiently cover...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653238/ |